13 Best Biotech Stocks To Invest In Now

4. Roivant Sciences Ltd. (NASDAQ:ROIV)

Number of Hedge Fund Holders: 53

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to invest in now. On June 16, Pulmovant, a Roivant company, announced the publication of Phase 1 pharmacokinetic/PK data for inhaled mosliciguat in healthy male volunteers. The peer-reviewed manuscript, titled “Pharmacokinetics and Lung Deposition After Administration of Inhaled Mosliciguat (BAY 1237592): Results from Randomized Phase I Studies in Healthy Men,” was published in the journal Clinical Pharmacokinetics.

The findings support the potential for once-daily inhaled administration of mosliciguat as a treatment option for patients with pulmonary hypertension/PH, suggesting a longer half-life compared to oral and IV administration, which could lead to limited systemic side effects. The published manuscript details three Phase 1 studies that characterized the PK profile of mosliciguat following inhalation via a low-resistance device using a lactose carrier-based dry powder formulation.

In all three studies, mosliciguat was well tolerated, with no major systemic effects observed on heart rate or blood pressure. The data indicate a long residence time for the drug in the lungs and a slow, continuous release into the systemic circulation. PH is a progressive and debilitating condition characterized by high blood pressure in the lungs’ blood vessels, which leads to symptoms like shortness of breath and fatigue.

Pulmovant is a clinical-stage biotechnology company and a Roivant company. Roivant Sciences Ltd. (NASDAQ:ROIV) is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes medicines and technologies.